Airway remodelling in asthma

Clinical and Experimental Allergy Reviews

Volumn 2, Issue 4, 2002, Pages 109-116

  Beasley, Richard ^a   Page, C ^b   Lichtenstein, L ^c  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Airway resistance; Asthma; Bronchoconstriction; Epithelium; Extracellular matrix; Fibrosis; Inflammation; Remodelling; Respiratory mechanics; Smooth muscle

Indexed keywords

ANTIASTHMATIC AGENT; CYTOKINE; GROWTH FACTOR; STEROID;

AIRWAY RESISTANCE; ANGIOGENESIS; ASTHMA; BREATHING MECHANICS; BRONCHOSPASM; CONFERENCE PAPER; DISEASE SEVERITY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HYPERPLASIA; MUCUS GLAND; MYOFIBROSIS; PRIORITY JOURNAL; SMOOTH MUSCLE;

EID: 3042777791     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2.s4.1.x     Document Type: Conference Paper

References (81)

1. Bousquet J, Chanez P, Lacoste JY et al. Asthma: a disease remodelling the airways. Allergy 1992; 47:3-11.
2. Vignola AM, Chanez P, Siena L, Chiappara G, Bonsignore G, Bousquet J. Airways remodelling in asthma. Pulm Pharmacol Ther 1998; 11:359-67.
3. Kips JC, Pauwels RA. Airway wall remodelling: does it occur and what does it mean? Clin Exp Allergy 1999; 29:1457-66.
4. Bousquet J, Vignola AM, Chanez P, Campbell AM, Bonsignore G, Michel FB. Airways remodelling in asthma: no doubt, no more? Int Arch Allergy Immunol 1995; 107:211-4.
5. Vrugt B, Wilson S, Bron A, Holgate ST, Djukanovic R, Aalbers R. Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J 2000; 15:1014-21.
6. Laviolette M, Bosse M, Chakir J, Boulet LP. Mechanisms of corticosteroid resistance in asthma: role of airway remodelling. Can Respir J 1998; 5:63-5.
7. Cohn JN, Ferrari R, Sharpe N. Cardiac remodelling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodelling. J Am Coll Cardiol 2000; 35:569-82.
8. Page C, Black J, eds. Airways and Vascular Remodelling. London: Academic Press, 1994.
9. Stewart AG, Tomlinson PR, Wilson J. Airway wall remodelling in asthma, a novel target for the development of anti-asthma drugs. Trends Pharmacol Sci 1993; 14:275-9.
10. Jeffery PK, Laitinen A, Venge P. Biopsy markers of airway inflammation and remodelling. Respir Med 2000; 94 (Suppl. F):S9-S15.
11. Homer RJ, Elias JA. Consequences of long-term inflammation. Airway remodeling. Clin Chest Med 2000; 21:331-43.
12. Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000; 105:1041-53.
13. Davies DE, Polosa R, Puddicombe SM et al. The epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma. Allergy 1999; 54:771-83.
14. Hegele RG. The pathology of asthma: brief review. Immunopharmacol 2000; 48:257-62.
15. Redington AE. Fibrosis and airway remodelling. Clin Exp Allergy 2000; 30 (Suppl. 1):42-5.
16. Martinez FD. Present and future treatment of asthma in infants and young children. J Allergy Clin Immunol 1999; 104:169-74.
17. Holgate ST, Lackie PM, Davies DE, Roche WR, Walls AF. The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy 1999; 29 (Suppl. 2):90-5.
18. Warner JO. Unmet needs in the treatment of asthmatic children and adolescents: 1. Clin Exp Allergy 2000; 30 (Suppl. 1):70-2.
19. Goldie RG, Fernandes LB, Rigsby PJ et al. Airway structure: a role for confocal microscopy? Pulmon Pharmacol Ther 1998; 11:349-54.
20. Takizawa H. Airway epithelial cells as regulators of airway inflammation. Int J Mol Med 1998; 1:367-78.
21. Holgate ST. Epithelial damage and response. Clin Exp Allergy 2000; 30 (Suppl. 1):37-41.
22. Goldie RG. Potential role of endothelins in airway remodelling in asthma. Pulm Pharmacol Ther 1999; 12:79-80.
23. Okona-Mensah KB, Shittu E, Page C, Costello J, Kilfeather SA. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin. Br J Pharmacol 1998; 125:599-606.
24. Duplaa C, Couffinhal T, Dufourcq P, Llanas Brigitte Moreau C, Bonnet J. The integrin very late antigen-4 is expressed in human smooth muscle cell. Involvement of alpha 4 and vascular cell adhesion molecule-1 during smooth muscle cell differentiation. Circ Res 1997; 80:159-69.
25. Kling D, Fingerle J, Harlan JM, Lobb RR, Lang F. Mononuclear leukocytes invade rabbit arterial intima during thickening formation via CD18- and VLA-4-dependent mechanisms and stimulate smooth muscle migration. Circ Res 1995; 77:1121-8.
26. Amrani Y, Panettieri RA. Cytokines induce airway smooth muscle cell hyperresponsiveness to contractile agents. Thorax 1998; 53:713-6.
27. Lee NA, Gelfand EW, Lee JJ. Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology? J Allergy Clin Immunol 2001; 107:945-57.
28. Warner JO, Pohunek P, Marguet C, Clough JB, Roche WR. Progression from allergic sensitization to asthma. Pediatr Allergy Immunol 2000; 11 (Suppl. 13):12-4.
29. Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001; 79:376-84.
30. Hall IP. Genetic factors in asthma severity. Clin Exp Allergy 1998; 28 (Suppl. 5):16-20.
31. Chung KF, Adcock IM. Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques. Mol Biotechnol 2001; 18:213-32.
32. Bascom R. Environmental factors and respiratory hypersensitivity: the Americas. Toxicol Lett 1996; 86:115-30.
33. Janson C, Anto J, Burney P et al. European Community Respiratory Health Survey II. The European Community Respiratory Health Survey: what are the main results so far? Eur Respir J 2001; 18:598-611.
34. Mattoli S. Allergen-induced generation of mediators in the mucosa. Environ Health Perspect 2001; 109 (Suppl. 4):553-7.
35. Schwartz DA. Etiology and pathogenesis of airway disease in children and adults from rural communities. Environ Health Perspect 1999; 107 (Suppl. 3):393-101.
36. Everard ML, Swarbrick A, Wrightham M et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994; 71:428-32.
37. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161:1501-7.
38. Bardana EJ Jr. Reactive airways dysfunction syndrome (RADS): guidelines for diagnosis and treatment and insight into likely prognosis. Ann Allergy Asthma Immunol 1999; 83:583-6.
39. Park JW, Hong YK, Kim CW, Kim DK, Choe KO, Hong CS. High-resolution computed tomography in patients with bronchial asthma, correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J Invest Allergol Clin Immunol 1997; 7:186-92.
40. Martin JG, Duguet A, Eidelman DH. The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease. Eur Respir J 2000; 16:349-54.
41. Johnson PR, Ammit AJ, Carlin SM, Armour CL, Caughey GH, Black JL. Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus. Eur Respir J 1997; 10:38-43.
42. Freyer AM, Johnson SR, Hall IP. Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells. Am J Respir Cell Mol Biol 2001; 25:569-76.
43. Johnson PR. Role of human airway smooth muscle in altered extracellular matrix production in asthma. Clin Exp Pharmacol Physiol 2001; 28:233-6.
44. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17.
45. Vignola AM, Chiappara G, Gagliardo R et al. Apoptosis and airway inflammation in asthma. Apoptosis 2000; 5:473-85.
46. Laprise C, Laviolette M, Boutet M, Boulet LP. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J 1999; 14:63-73.
47. Roche WR, Beasley R, Williams JH, Holgate ST. Sub-epithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1:520-4.
48. Tremblay GM, Chakir J, Boulet LP, Jordana M, Richards CD, Gauldie J. Bronchial myofibroblasts and tissue remodelling in asthma. Can Respir J 1998; 5:59-61.
49. Bonner JC, Rice AB, Moomaw CR, Morgan DL. Airway fibrosis in rats induced by vanadium pentoxide. Am J Physiol Lung Cell Mol Physiol 2000; 278:L209-16.
50. Laitinen LA, Altraja A, Karjalainen EM, Laitinen A. Early interventions in asthma with inhaled corticosteroids. J Allergy Clin Immunol 2000; 105:S582-S585.
51. Laitinen LA, Altraja A, Kampe M et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997; 156:951-8.
52. Mautino G, Henriquet C, Jauffuel D, Bousquet J, Capony F. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. Am J Respir Crit Care Med 1999; 160:324-30.
53. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 1998; 50:515-96.
54. Jeffery PK. Microscopic anatomy. In: Brewis RAL, Gibson GJ, Geddes DM, eds. Respiratory Medicine. London/Toronto: Bailliere Tindall, 1995; 57-78.
55. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992; 101:916-21.
56. Wilson J. The bronchial microcirculation in asthma. Clin Exp Allergy 2000; 30 (Suppl. 1):51-3.
57. Spina D. Airway sensory nerves: a burning issue in asthma? Thorax 1996; 51:335-7.
58. Harrison S, Page CP, Spina D. Airway nerves and protein phosphatases. Gen Pharmacol 1999; 32:287-98.
59. Ädelroth E. How to measure airway inflammation. bronchoalveolar lavage and airway biopsies. Can Respir J 1998; 5 (Suppl. A):18A-21A.
60. Humbert M, Durham SR, Kimmitt P et al. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997; 99:657-65.
61. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70:171-9.
62. Grazzini M, Scano G, Foglio K et al. Relevance of dyspnoea and respiratory function measurements in monitoring of asthma: a factor analysis. Respir Med 2001; 95:246-50.
63. Ng TP. Validity of symptom and clinical measures of asthma severity for primary outpatient assessment of adult asthma. Br J Gen Pract 2000; 50:7-12.
64. Sheffer AL, Bartal M, Bousquet J et al. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop report 1995 publication no. 95-3659. www.ginasthma.com
65. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143:138-43.
66. Brown RH, Zerhouni E. New techniques and developments in physiologic imaging of airways. Radiol Clin North Am 1998; 36:211-30.
67. Pauwels RA, Busse WW, O'Byrne PM et al. The inhaled steroid treatment as regular therapy in early asthma (START) study. Rationale and design. Control Clin Trials 2001; 22:405-19.
68. Saetta M, Maestrelli P, Turato G et al. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 1995; 151:489-94.
69. Boulet LP. Asthma therapy: effects on airway inflammation and remodelling. Can Respir J 1998; 5:68-70.
70. Bosse M, Chakir J, Rouabhia M et al. Serum matrix metalloproteinase-9. Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999; 159:596-602.
71. Lundgren R, Soderberg M, Horstedt P, Stenling R. Morphological studies on bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Resp J 1988; 1:883-9.
72. Olivieri D, Chetta A, Del Donno M et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodelling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997; 155:1864-71.
73. Hoshino M, Takahashi M, Takai Y, Sim J, Aoike N. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999; 104:530-3.
74. Orsida BE, Ward C, Li X et al. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodelling in asthma. Am J Respir Crit Care Med 2001; 164:117-21.
75. 2-agonists. Lancet 1991; 337:717-20.
76. Lin KC, Castro AC. Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents. Curr Opin Chem Biol 1998; 2:453-7.
77. Nissen SE. Rationale for a post-intervention continuum of care: insights from intravascular ultrasound. Am J Cardiol 2000; 86:12H-17H.
78. Demoly P, Bousquet J, Michel FB. Immunotherapy in allergic rhinitis: a prevention for asthma? Curr Prob Dermatol 1999; 28:119-23.
79. Valovirta E. PAT - the Preventive Allergy Treatment Study design and preliminary results. Wien Med Wochenschr 1999; 149:442-3.
80. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342:821-8.
81. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336:525-33.